NCT01695330 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- patients with MM who received treatment with a SC bortezomib-containing combination. The patients were required to have received a prior IV bortezomib containing combination regimen that differs from the SC bortezomib-containing treatment.
- id
- FG000
- title
- Subcutaneous Bortezomib
- description
- This is one-arm study.
- id
- FG001
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 52
- group Id
- FG001
- num Subjects
- 0
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 5
- group Id
- FG001
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 47
- group Id
- FG001
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
- recruitment Details
- Patients with MM who received treatment with a SC bortezomib-containing combination
Complete source fields
- groups
- description
- patients with MM who received treatment with a SC bortezomib-containing combination. The patients were required to have received a prior IV bortezomib containing combination regimen that differs from the SC bortezomib-containing treatment.
- id
- FG000
- title
- Subcutaneous Bortezomib
- description
- This is one-arm study.
- id
- FG001
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 52
- group Id
- FG001
- num Subjects
- 0
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 5
- group Id
- FG001
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 47
- group Id
- FG001
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
- recruitment Details
- Patients with MM who received treatment with a SC bortezomib-containing combination
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle